BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bagheri Tudashki H, Haddad Y, Charfi I, Couture R, Pineyro G. Ligand-specific recycling profiles determine distinct potential for chronic analgesic tolerance of delta-opioid receptor (DOPr) agonists. J Cell Mol Med 2020;24:5718-30. [PMID: 32279433 DOI: 10.1111/jcmm.15234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Bodnar RJ. Endogenous opiates and behavior: 2020. Peptides 2022. [DOI: 10.1016/j.peptides.2022.170752] [Reference Citation Analysis]
2 Mansour A, Nagi K, Dallaire P, Lukasheva V, Le Gouill C, Bouvier M, Pineyro G. Comprehensive Signaling Profiles Reveal Unsuspected Functional Selectivity of δ-Opioid Receptor Agonists and Allow the Identification of Ligands with the Greatest Potential for Inducing Cyclase Superactivation. ACS Pharmacol Transl Sci 2021;4:1483-98. [PMID: 34661070 DOI: 10.1021/acsptsci.1c00019] [Reference Citation Analysis]
3 Pineyro G, Nagi K. Signaling diversity of mu- and delta- opioid receptor ligands: Re-evaluating the benefits of β-arrestin/G protein signaling bias. Cell Signal 2021;80:109906. [PMID: 33383156 DOI: 10.1016/j.cellsig.2020.109906] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Bagheri Tudashki H, Haddad Y, Charfi I, Couture R, Pineyro G. Ligand-specific recycling profiles determine distinct potential for chronic analgesic tolerance of delta-opioid receptor (DOPr) agonists. J Cell Mol Med 2020;24:5718-30. [PMID: 32279433 DOI: 10.1111/jcmm.15234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]